(LULU, ARNA, MTSN) CRWENewswire Stocks In ActionGood Morning, It’s Tuesday Jan. 10, 2012, I’m Christina Collins with CRWENewswire Stocks In Action. Arena Pharmaceuticals Inc - ARNA - and Eisai Inc. reported that the FDA has accepted for filing and review Arena’s resubmission of the New Drug Application for lorcaserin. For the fourth quarter of fiscal 2011, Lululemon Athletica Inc - LULU - now expects diluted earnings per share to be in the range of $0.47 to $0.49 as compared to its previous guidance range for diluted earnings per share of $0.40 to $0.42. and lastly; Mattson Technology Inc - MTSN - reported that it has won acceptance for its Helios XP rapid thermal processing system from another leading semiconductor manufacturer. Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins
*********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer )
